Anteris Technologies Global (NASDAQ:AVR) Upgraded to “Strong-Buy” at Cantor Fitzgerald

Anteris Technologies Global (NASDAQ:AVR) was upgraded by investment analysts at Cantor Fitzgerald to a “strong-buy” rating in a research report issued to clients and investors on Wednesday,Zacks.com reports.

Several other research analysts have also recently commented on the stock. Weiss Ratings reiterated a “sell (e+)” rating on shares of Anteris Technologies Global in a report on Monday, December 29th. Lake Street Capital reissued a “buy” rating and issued a $15.00 price target on shares of Anteris Technologies Global in a research note on Friday, January 23rd. One analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Anteris Technologies Global presently has a consensus rating of “Moderate Buy” and an average price target of $15.00.

Anteris Technologies Global Price Performance

Shares of NASDAQ:AVR opened at $6.35 on Wednesday. The company has a market capitalization of $261.62 million, a PE ratio of -2.48 and a beta of 1.15. The company has a debt-to-equity ratio of 0.01, a quick ratio of 0.73 and a current ratio of 0.73. The stock has a fifty day moving average of $5.62 and a 200-day moving average of $4.89. Anteris Technologies Global has a one year low of $2.34 and a one year high of $8.36.

Anteris Technologies Global (NASDAQ:AVR) last announced its earnings results on Thursday, February 26th. The company reported ($0.75) earnings per share (EPS) for the quarter. Anteris Technologies Global had a negative return on equity of 536.04% and a negative net margin of 4,921.27%.The company had revenue of $0.31 million for the quarter. As a group, equities analysts anticipate that Anteris Technologies Global will post -2.66 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, major shareholder L1 Capital Pty Ltd bought 5,000,000 shares of the firm’s stock in a transaction on Thursday, January 22nd. The stock was purchased at an average price of $5.75 per share, with a total value of $28,750,000.00. Following the completion of the transaction, the insider directly owned 13,219,814 shares of the company’s stock, valued at $76,013,930.50. This trade represents a 60.83% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 4.50% of the company’s stock.

Institutional Trading of Anteris Technologies Global

A number of institutional investors and hedge funds have recently modified their holdings of the company. Marex Group plc bought a new stake in Anteris Technologies Global during the second quarter valued at about $641,000. Affinity Asset Advisors LLC increased its stake in shares of Anteris Technologies Global by 9.0% in the second quarter. Affinity Asset Advisors LLC now owns 425,000 shares of the company’s stock worth $1,611,000 after purchasing an additional 35,000 shares during the period. Intech Investment Management LLC acquired a new position in shares of Anteris Technologies Global during the 2nd quarter worth about $49,000. Bank of America Corp DE lifted its position in shares of Anteris Technologies Global by 35.7% during the 3rd quarter. Bank of America Corp DE now owns 10,631 shares of the company’s stock worth $48,000 after purchasing an additional 2,798 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in Anteris Technologies Global by 35.2% during the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,744 shares of the company’s stock valued at $45,000 after purchasing an additional 3,055 shares during the period.

About Anteris Technologies Global

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.